BioSpace: Biotech, Pharmaceutical and Clinical Research News
The stock market—and biotech insiders—reacted negatively to the allegedly forced resignation of CBER Director Peter Marks, who said RFK Jr. does not seek “truth and transparency” but …
About Us - BioSpace
BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who …
News - BioSpace
The latest biotech and pharmaceutical news from BioSpace
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
Jan 6, 2025 · Facing increasing global pressure, WuXi Biologics will sell its Ireland vaccines facility to Merck for $500 million.. The two companies have been collaborating on the Dundalk …
Sorriso Pharmaceuticals Announces Positive Phase 1b Clinical Trial ...
BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who …
Layoffs Continued Across Biopharma in 2024 - BioSpace
Dec 31, 2024 · Kronos Bio Nov. 27. Kronos Bio on Wednesday announced that it will trim its headcount by approximately 83% by the end of the year, as part of a previously announced …
BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace
5 days ago · 2024 was a tough year for the biopharma industry, with several companies including Bayer, Bristol Myers Squibb and Johnson & Johnson cutting hundreds or even thousands of …
5 Clinical Assets That Flopped in 2024 - BioSpace
Dec 16, 2024 · Schizophrenia. In December 2023, AbbVie bet $8.7 billion on Cerevel Therapeutics, with high hopes for the biotech’s lead asset emraclidine. These hopes—and a …
Join Our Team - BioSpace
BioSpace is the digital hub for life sciences news and jobs. Our mission is to provide essential insights, tools, and opportunities to connect the innovative organizations and talented …
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market
Nov 21, 2024 · Ahead of its investor event Thursday, Novartis revealed it is acquiring California-based biotech Kate Therapeutics, a move that “compliments” the pharma’s push to deliver …